Table 1 Description of clinical variables
Clinical | n | (%) |
|---|---|---|
Clinical tumor size (cT) | ||
cT1a – cT2a | 270 | (54.7) |
cT2b – cT2c | 141 | (25.8) |
cT3 – cT4 | 66 | (13.4) |
NA | 17 | (3.4) |
Initial PSA (ng/mL) | ||
<10 | 306 | (61.9) |
10 – 19.99 | 103 | (20.9) |
>20 | 79 | (16.0) |
NA | 6 | (1.2) |
Gleason score | ||
<7 | 226 | (45.7) |
7 | 195 | (39.5) |
>7 | 71 | (14.4) |
NA | 2 | (0.4) |
D’Amico group | ||
Low | 120 | (24.3) |
Intermediate | 184 | (37.2) |
High | 173 | (35.0) |
NA | 17 | (3.4) |